| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999600 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
AO exposure was not associated with worse preoperative characteristics such as elevated prostate-specific antigen levels or biopsy GS nor with BCR, secondary treatment, metastases, or PC death. Thus, as data on AO-exposed men mature, possible differences in PC outcomes observed previously are no longer apparent.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Aaron E. Ovadia, Martha K. Terris, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Stephen J. Freedland, Michael R. M.D.,